Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Lisata Therapeutics (LSTA) Income from Non-Controlling Interests (2016 - 2019)

Lisata Therapeutics filings provide 10 years of Income from Non-Controlling Interests readings, the most recent being $1000.0 for Q3 2019.

  • For the quarter ending Q3 2019, Income from Non-Controlling Interests changed 0.0% year-over-year to $1000.0, compared with a TTM value of $1000.0 through Sep 2023, changed N/A, and an annual FY2020 reading of $9000.0, changed 0.0% over the prior year.
  • Income from Non-Controlling Interests hit $1000.0 in Q3 2019 for Lisata Therapeutics, down from $3000.0 in the prior quarter.
  • The five-year high for Income from Non-Controlling Interests was $3000.0 in Q2 2019, with the low at -$368831.0 in Q1 2017.
  • Median Income from Non-Controlling Interests over the past 5 years was -$31292.0 (2015), compared with a mean of -$48947.8.
  • The sharpest move saw Income from Non-Controlling Interests plummeted 451.49% in 2017, then skyrocketed 400.0% in 2019.
  • Year by year, Income from Non-Controlling Interests stood at -$31292.0 in 2015, then plummeted by 144.58% to -$76533.0 in 2016, then skyrocketed by 98.9% to -$844.0 in 2017, then soared by 218.48% to $1000.0 in 2018, then changed by 0.0% to $1000.0 in 2019.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at $1000.0, $3000.0, and $2000.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.